Posted by Michael Wonder on 18 Feb 2026
New Alzheimer’s drug won’t be covered by Dutch health insurance
18 February 2026 - A new drug for treating Alzheimer’s has only a marginal impact on people with the early stages of the memory loss disease and should not be included in the basic health insurance package, according to the Dutch health institute Zorginstituut Nederland.
The institute recommends which drugs should qualify for inclusion in the health insurance system and its proposals are generally adopted by the government which is responsible for determining basic insurance coverage.
